TNBC refers to breast cancer that is lacking both hormone receptors, the estrogen receptor (ER) and progesterone receptor (PR), in addition to lack of Human Epidermal Growth Factor Receptor-2 (HER2) amplification. This evidence concerns the gene ESR1 and breast carcinoma.